Organon & Co. is a global healthcare company that develops and markets prescription medicines and medical devices in women's health and general medicines across more than 140 countries. The company's primary focus is women's health, including contraceptive products, fertility treatments, and postpartum care devices, alongside a portfolio of biosimilar and established branded medicines addressing cardiovascular, respiratory, dermatological, and pain management needs. Organon generates revenue through sales to drug wholesalers, retailers, hospitals, government agencies, and managed healthcare providers, with distribution weighted toward international markets, particularly Europe, Canada, Asia Pacific, and China.